- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-11-0019606

About Eppion Lifesciences Private Limited
Data last updated:
Eppion Lifesciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2016PTC292259. Its GSTIN is 07AAECE2169F1ZS (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ameesh Garg and Raj Kumar Garg.
Its last annual general meeting (AGM) was held on 27 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Gh – 3/145 Paschim Vihar, New Delhi, Delhi, India – 110063.
As per the financials filed for FY 2025, the company reported a revenue of ₹113.59 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹60.67 Lakh (net margin 0.5%) and EBITDA of ₹1.24 Cr (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 5% over five years.
The company is associated with 1 brand: Eppionlifesciences. As per MCA filings, the company has open charges of ₹9.95 Cr and satisfied charges of ₹14.8 Cr on record. Court records list 58 cases involving the company, including 55 filed by the company and 3 filed against it; 51 cases are pending. The company has 2 deals on record (2 secondary share transfers); the latest was in March 2023. Its 7 peer companies in the Pharma industry (Lifesciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 3 smaller; the largest is Vasu Pharma Drugs Private Limited with revenue of ₹117.34 Cr.
Eppion Lifesciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0019606). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eppionlifesciences.in.
Company details
Recognitions & Rankings of Eppion Lifesciences
Contact details
Eppion Lifesciences Private Limited's registered office is in New Delhi, Delhi. Its website is eppionlifesciences.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGh – 3/145 Paschim Vihar, New Delhi, Delhi, India – 110063
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Eppion Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Eppion Lifesciences operates one associated brand: Eppionlifesciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Importer and supplier of pharmaceutical APIs and chemicals in India. | eppionlifesciences.in |
Business activity
The main business activity of Eppion Lifesciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eppion Lifesciences Private Limited, buy the company report.
Financials of Eppion Lifesciences Private Limited
FY 2024 filings availableEppion Lifesciences Private Limited reported revenue of ₹113.59 Cr (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 13% growth in the latest year. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.24 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹60.67 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eppion Lifesciences Private Limited, buy the company report.
Board of directors of Eppion Lifesciences Private Limited
Eppion Lifesciences has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ameesh Garg Also directs: Eppion Biotech LLP, Deedag Permalife LLP | Director | 17 May 2021 | 5 Years 5 Months | Current |
| Raj Kumar Garg Also directs: Eppion Biotech LLP | Director | 08 Mar 2016 | 10 Years 7 Months | Current |
| Puneet Garg Also directs: Eppion Biotech LLP | Director | 08 Mar 2016 | 10 Years 7 Months | Current |
| Ankur Garg Also directs: Eppion Biotech LLP, Deedag Permalife LLP | Director | 08 Mar 2016 | 10 Years 7 Months | Current |
Peer comparison
Eppion Lifesciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Lifesciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vasu Pharma Drugs Private Limited | ₹117.34 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Kasiviswanathan Medical Agencies Private Limited | ₹116.03 Cr (FY 2025) | 11.0% | Madurai, Tamil Nadu, India | |||
| Vasu Organics Private Limited | ₹115.97 Cr (FY 2025) | 19.0% | Hyderabad, Telangana, India | |||
| Rudrashri Lifesciences Private Limited | ₹114.31 Cr (FY 2024) | 3721.0% | Gandhidham, Gujarat, India | |||
| Eppion Lifesciences Private Limitedthis company | ₹113.59 Cr (FY 2025) | ₹60.67 Lakh | 0.5% | 13.0% | New Delhi, Delhi, India | |
| Concept Biosciences India Private Limited | ₹113.59 Cr (FY 2019) | 15.0% | Howrah, West Bengal, India | |||
| Dalvkot Utility Enterprises Private Limited | ₹112.96 Cr (FY 2024) | 25.0% | Bangalore, Karnataka, India | |||
| Morepen RX Limited | ₹112.79 Cr (FY 2025) | 35.0% | Nalagarh, Himachal Pradesh, India |
To see the full peer comparison of Eppion Lifesciences Private Limited, buy the company report.
Auditor
Eppion Lifesciences Private Limited is audited by GAURAV GOYAL AND ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GAURAV GOYAL AND ASSOCIATES | FY 2024 | 0017858N |
Shareholding
The shareholding of Eppion Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Eppion Lifesciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Oct 2023 | 100823364 | Hdfc Bank Limited | ₹9.95 Cr | Open | |
| 19 Feb 2021 | 100417229 | Others | ₹9.5 Cr | Satisfied | |
| 25 Jan 2019 | 100233510 | Others | ₹5.3 Cr | Satisfied |
To see the full charge records of Eppion Lifesciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Eppion Lifesciences Private Limited has 2 deals on record (2 secondary share transfers); the latest was in March 2023.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Eppion Lifesciences Private Limited has 58 court cases on record: 55 filed by Eppion Lifesciences, 3 filed against it. 51 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 56 | 1 | 51 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 58)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Sigma Softgel Private Limited Through Its Authorised Signatory/ Director (S) SH. Mrinal Ghatti and 3 others | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Dermiderm Biotech Private Ltd. | Pending |
| District court, Panchkula, Haryana | Cheque dishonour complaint | Filed by the company against M/S Taksa Life Science and 2 others | Pending |
| District court, West, Delhi | Revision petition | Filed against the company by Nityam Pharma and Ors | Disposed |
| High Court of Delhi | Court case (CM(M)) | Filed against the company by an individual | Disposed |
To see the full case history of Eppion Lifesciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eppion Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eppion Lifesciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECE2169F1ZS | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Eppion Lifesciences Private Limited, buy the company report.
Recent activity
Eppion Lifesciences Private Limited has 4 board changes on record since 2016: 4 appointments. The latest: Ameesh Garg was appointed as Director on 17 May 2021.
2 earlier events are in the company report.
Frequently asked questions
Eppion Lifesciences is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 March 2016 (10+ years old) and is registered under CIN U74999DL2016PTC292259.
Eppion Lifesciences has 4 current directors:
- Ameesh Garg - Director
- Raj Kumar Garg - Director
- Puneet Garg - Director
- Ankur Garg - Director
The latest financial statements of Eppion Lifesciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 27 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Eppion Lifesciences is 07AAECE2169F1ZS, registered in Delhi.
The CIN (Corporate Identification Number) of Eppion Lifesciences is U74999DL2016PTC292259. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eppion Lifesciences has 58 court cases on record: 55 filed by the company and 3 filed against it. 51 are pending. Most are in the district courts.
Eppion Lifesciences was incorporated on 08 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Eppion Lifesciences has 2 deals on record (2 secondary share transfers); the latest was in March 2023.
The peers of Eppion Lifesciences by revenue are Vasu Pharma Drugs Private Limited, Kasiviswanathan Medical Agencies Private Limited, Vasu Organics Private Limited, Rudrashri Lifesciences Private Limited, Concept Biosciences India Private Limited and 2 more, all in the Pharma industry (Lifesciences, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ameesh Garg was appointed as Director on 17 May 2021. Ankur Garg was appointed as Director on 08 Mar 2016. Puneet Garg was appointed as Director on 08 Mar 2016. Eppion Lifesciences has 4 board changes on record in total.
Yes, Eppion Lifesciences is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-11-0019606).

